VYALEV™ is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease Adults treated with VYALEV ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Continuous ...
Continuous subcutaneous foslevodopa-foscarbidopa improved motor symptoms and reduced motor fluctuations compared with oral levodopa-carbidopa in patients with advanced Parkinson’s disease, according ...
The Scottish Medicines Consortium (SMC) has approved foslevodopa-foscarbidopa (Produodopa, AbbVie Ltd), a new soluble formulation of levodopa/carbidopa pro-drugs, for restricted use on the NHS in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback